Quick Answer: GLP-1 receptor agonists are being investigated for potential neuroprotective effects in Alzheimer's disease, but they are not FDA-approved for dementia prevention or treatment
Trout AT, Chow J, McNamara ER, Darge K, Ramirez Grueso R, Munden M, Rothan SM, Navarro OM, Tijerin Bueno M, Bove KE, Chikwava KR, Heider A, Hicks MJ, Somers GR, Zhang B, Dillman JR (2017) Association between Testicular Microlithiasis and Testicular Neoplasia: Large Multicenter Study in a Pediatric Population
This is especially relevant for patients with polycystic ovarian syndrome
Further studies are needed to evaluate the causal relationship and GLP-1 RA safety with concomitant medication use
Regardless of the advances, there is no clear evidence of the long-term effect of hydroxyurea in preventing end organ damage (Nevitt et al., 2017